Pfizer Acquires Most cancers Therapy Biotech Agency Seagen For $43 Billion

Pfizer will purchase biotech agency Seagen for 43 billion {dollars}. (Representational)

Paris:

US pharmaceutical large Pfizer introduced Monday it reached a deal to purchase biotech agency Seagen, specialising in revolutionary most cancers therapy, for $43 billion. 

“Pfizer is deploying its monetary assets to advance the battle in opposition to most cancers,” mentioned Pfizer CEO Albert Bourla. 

(Apart from the headline, this story has not been edited by NDTV workers and is printed from a syndicated feed.)